| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | CA2439078C Composition improving age-related physiological deficits and increasing longevity |
| 08/25/2009 | CA2385302C Receptor proteins specifically recognizing bacterial dna |
| 08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/20/2009 | WO2009103007A2 Steroid hormone receptor modulator compounds and methods |
| 08/20/2009 | WO2009102893A2 CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors |
| 08/20/2009 | WO2009102496A2 Selective agonist of toll-like receptor 3 |
| 08/20/2009 | WO2009102468A1 6-aryl-imidaz0[l, 2-a] pyrazine derivatives, method of making, and method of use thereof |
| 08/20/2009 | WO2009102465A2 Continuous cell programming devices |
| 08/20/2009 | WO2009102050A1 Intestinal immune system stimulator |
| 08/20/2009 | WO2009101475A2 Use of glycosylceramides for enhancing the immune response to antigens |
| 08/20/2009 | WO2009100955A1 Antisense rna targeting cxcr4 |
| 08/20/2009 | WO2009100505A1 Immunogenic peptides and their use in transplantation |
| 08/20/2009 | WO2009100502A1 Immunostimulatory sirna molecules |
| 08/20/2009 | WO2009080934A3 Allergen desensitization method |
| 08/20/2009 | WO2009067699A3 Methods for providing a system of care for an oxazaphosphorine drug regimen |
| 08/20/2009 | WO2009046872A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009043889A3 Oxadiazole derivatives |
| 08/20/2009 | WO2009033808A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009033765A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009033754A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009029342A3 B7-dc variants |
| 08/20/2009 | WO2009002372A3 Prevention and treatment of gram negative, flagellated bacterial infections |
| 08/20/2009 | US20090209905 Compositions comprising chitin microparticles and their medical uses |
| 08/20/2009 | US20090209729 Recombinant chemokine-antigen vaccine |
| 08/20/2009 | US20090209650 Materials and Methods for Improving the health of Shrimp |
| 08/20/2009 | US20090209585 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 08/20/2009 | US20090209581 Nitroxides for use in treating or preventing immunological diseases |
| 08/20/2009 | US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof |
| 08/20/2009 | US20090209559 Pharmaceutical compounds |
| 08/20/2009 | US20090209516 9-amino-acridine derivatives and method of treating autoimmune diseases using the same |
| 08/20/2009 | US20090209004 Human il-1 beta antagonists |
| 08/20/2009 | US20090208581 Formulations limiting spread of pulmonary infections |
| 08/20/2009 | US20090208562 Vaccine Composition Comprising a Fibronectin Binding Protein or a Fibronectin Binding Peptide |
| 08/20/2009 | US20090208552 Cross-linked fatty acid-based biomaterials |
| 08/20/2009 | US20090208535 Novel Methods of Diagnosis of Treatment of P. Aeruginosa Infection and Reagents Therefor |
| 08/20/2009 | US20090208523 Adjuvant for vaccines |
| 08/20/2009 | US20090208521 Pharmaceutical compositions containing protein nma0939 |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | US20090208488 Regulation of dendritic cell functions by the DCAL-2 receptor |
| 08/20/2009 | US20090208487 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 08/20/2009 | US20090208471 Isolation and Use of Human Regulatory T Cells |
| 08/20/2009 | US20090208451 Halogen phosphonate monoesters |
| 08/20/2009 | US20090208447 Polypeptides |
| 08/20/2009 | US20090208416 Monoclonal antibodies against nkg2a |
| 08/20/2009 | CA2715517A1 Immunogenic peptides and their use in transplantation |
| 08/20/2009 | CA2715460A1 Continuous cell programming devices |
| 08/20/2009 | CA2715293A1 Selective agonist of toll-like receptor 3 |
| 08/20/2009 | CA2714414A1 Certain substituted amides, method of making, and method of use thereof |
| 08/20/2009 | CA2708246A1 Compositions for and methods of enhancing the immune response to antigens |
| 08/19/2009 | EP2090657A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP2090583A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2090318A1 Prophylactic tuberculosis vaccine |
| 08/19/2009 | EP2090304A2 Use of sugar phosphates, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycose-enzyme complex, the malate aspartate shuttle and/or transaminases |
| 08/19/2009 | EP2090177A1 Food products having enhanced cocoa polyphenol content |
| 08/19/2009 | EP2089514A1 Cancerous disease modifying antibodies |
| 08/19/2009 | EP2089428A2 Crystalline anti-htnfalpha antibodies |
| 08/19/2009 | EP2089389A2 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-1, and/or nf-kappa-b activity |
| 08/19/2009 | EP2089369A2 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 08/19/2009 | EP2089057A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 08/19/2009 | EP1971369B1 Combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflammatory diseases |
| 08/19/2009 | EP1590334B1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/19/2009 | EP1497467B1 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 08/19/2009 | EP1482973B1 Methods of modulating cd200 receptors |
| 08/19/2009 | EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES |
| 08/19/2009 | EP1414466B1 Combinations for the treatment of inflammatory disorders |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP1183240B1 Beta2-adrenoceptor agonists |
| 08/19/2009 | CN101511827A Pyridin-4-yl derivatives as immunomodulating agents |
| 08/19/2009 | CN101511823A Multifunctional bioactive compounds |
| 08/19/2009 | CN101511359A Benzotriazole kinase modulators |
| 08/19/2009 | CN101511350A Dioxo-alkanes and dioxo-alkenes |
| 08/19/2009 | CN101508739A Radio frequency auxiliary method for extracting glossy ganoderma seed polysaccharide |
| 08/19/2009 | CN101508734A Anti-CD40 monoclonal antibody |
| 08/19/2009 | CN101508693A Xylogen like flavonoid compounds, method of preparing the same and pharmaceutical use |
| 08/19/2009 | CN101508671A Aza saccharide compounds, synthesis and uses thereof |
| 08/19/2009 | CN101507803A Health-protection medicine granule |
| 08/19/2009 | CN101507773A Traditional Chinese medicine composite for treating eczema and preparation method thereof |
| 08/19/2009 | CN101507744A Chinese herbal medicine immunopotentiator composite for young fish of catostomid fish and preparation method thereof |
| 08/19/2009 | CN101507734A Deer-bone serial processing method |
| 08/19/2009 | CN101507709A Interleukin -2 liposome and preparation method thereof |
| 08/19/2009 | CN101507563A Production method of silk quilt capable of increasing human immunity |
| 08/19/2009 | CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/19/2009 | CN100529076C Mammalian cytokines, related reagents and methods |
| 08/19/2009 | CN100529074C Therapeutic binding molecules |
| 08/19/2009 | CN100528897C Modified soluble t cell receptor |
| 08/19/2009 | CN100528874C Pyrrolo [2,3d] pyrimidine compositions and their use |
| 08/19/2009 | CN100528869C Silybin flavonolignan and their production method and use |
| 08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528240C Preparation method and medicinal uses of Trichinella eelworm vaccine |
| 08/19/2009 | CN100528225C Methods for the in vitro culture of sporozoea species and uses thereof |
| 08/19/2009 | CN100528222C Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 08/19/2009 | CN100528169C Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food |
| 08/19/2009 | CN100528165C Stable medicine composition of setastine or its salt |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 08/18/2009 | US7576193 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |